Zinc carnosine-based modified bismuth quadruple therapy vs standard triple therapy for Helicobacter pylori eradication: A randomized controlled study

doi:10.12998/wjcc.v10.i1.227

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5408)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

361

WORD

129

HTML

2742

Figures (1-2)

229

Tables (1-2)

333

Sum=3794

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

415

Download

1199

Sum=1614

Jan 7, 2022 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Clin Cases. Jan 7, 2022; 10(1): 227-235
Published online Jan 7, 2022. doi: 10.12998/wjcc.v10.i1.227

Open in New Tab Full Size Figure Download Figure

Figure 1 Eradication rate of Helicobacter pylori infection by therapy type. MBGT: Modified bismuth quadruple therapy; TT: Triple therapy; UBT: Urea breath test.

Open in New Tab Full Size Figure Download Figure

Figure 2 Reported adverse effects in each treatment group. MBGT: Modified bismuth quadruple therapy; TT: Triple therapy.

Citation: Ibrahim N, El Said H, Choukair A. Zinc carnosine-based modified bismuth quadruple therapy vs standard triple therapy for Helicobacter pylori eradication: A randomized controlled study. World J Clin Cases 2022; 10(1): 227-235
URL: https://www.wjgnet.com/2307-8960/full/v10/i1/227.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i1.227